In addition, it has been shown that higher NAFLD activity is associated with reduced visceral adipose tissue chemerin gene expression in patients with NAFLD, pointing towards a role of adipose tissue in reduced chemerin levels in advanced liver disease29. This evidence concerns the gene RARRES2 and metabolic dysfunction-associated steatotic liver disease.